Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Non-cash Items: 2016-2017

  • Ultragenyx Pharmaceutical's Non-cash Items rose 108.88% to $165.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $165.3 million, marking a year-over-year increase of 108.88%. This contributed to the annual value of $2.7 million for FY2017, which is 96.58% down from last year.
  • Per Ultragenyx Pharmaceutical's latest filing, its Non-cash Items stood at $165.3 million for Q4 2017, which was up 108.88% from $79.1 million recorded in Q4 2016.
  • Ultragenyx Pharmaceutical's 5-year Non-cash Items high stood at $165.3 million for Q4 2017, and its period low was $79.1 million during Q4 2016.
  • Moreover, its 2-year median value for Non-cash Items was $122.2 million (2016), whereas its average is $122.2 million.
  • Data for Ultragenyx Pharmaceutical's Non-cash Items shows a peak YoY surged of 108.88% (in 2017) over the last 5 years.
  • Ultragenyx Pharmaceutical's Non-cash Items (Quarterly) stood at $79.1 million in 2016, then soared by 108.88% to $165.3 million in 2017.